Related Experiment Video
Updated: Jun 23, 2026

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
Mutant huntingtin disrupts TET1 transcription and alters DNA methylation in a Huntington's disease knock-in pig model
Leijie Xie1, Xiaodong Liu1, Can Zhang1
1State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Guangdong-Hong Kong-Macau Institute of CNS Regeneration, Jinan University, Guangzhou, China; Guangdong Provincial Key Laboratory of Non-human Primate Research, Jinan University, Guangzhou, China.
Abstract:
Abnormal DNA methylation occurs in Huntington's disease (HD, but the underlying mechanisms remain unclear. Using a knock-in pig model, we identify significant alterations in 5mC and 5hmC levels linked to neural genes. TET1, which converts 5mC to 5hmC, decreases prior to symptom onset in pigs-a change not observed in HD mice. TBP binding sites are abundant in the porcine and human TET1 promoter, but scarce in mice. Mutant huntingtin (mHTT) binds more strongly to TBP in HD pig brains, blocking TBP's access to the TET1 promoter, thereby reducing TET1 transcription and altering 5mC/5hmC patterns. Our findings reveal TET1 as a target of abnormal DNA methylation that contributes to selective neuronal vulnerability in HD pigs, highlighting the value of large mammalian models for studying disease pathogenesis.
Related Concept Videos
Huntington Disease l: Introduction
Hedgehog Signaling Pathway
In-vitro Mutagenesis
Pleiotropy

